Indocin and Swelling - a phase IV clinical study of FDA data

Summary:

Swelling is reported as a side effect among people who take Indocin (indomethacin), especially for people who are female, 50-59 old, also take Zometa, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Swelling when taking Indocin. It is created by eHealthMe based on reports of 4,328 people who have side effects when taking Indocin from the FDA, and is updated regularly.

What is Indocin?

Indocin has active ingredients of indomethacin. It is often used in gout. eHealthMe is studying from 4,559 Indocin users. Check the latest studies of Indocin.

What is Swelling?

Swelling is found to be associated with 2,298 drugs and 2,891 conditions by eHealthMe. Check the latest studies of Swelling.

On Jul, 09, 2026

4,328 people reported to have side effects when taking Indocin.
Among them, 66 people (1.52%) have Swelling.

Among these 66 people:

What is the gender of people who have Swelling when taking Indocin? *

female: 59.68 %
male: 40.32 %

What is the age of people who have Swelling when taking Indocin? *

What are other drugs people take besides Indocin? *

What are other side effects people have besides Swelling? *

Dizziness: 33 people, 50.00%
Stress And Anxiety: 32 people, 48.48%
Rotator Cuff Syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder): 27 people, 40.91%
Fatigue (feeling of tiredness): 26 people, 39.39%
Mouth Ulcers: 25 people, 37.88%
High Blood Pressure: 23 people, 34.85%
Inflammation: 23 people, 34.85%
Pain In Jaw: 21 people, 31.82%
Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 30.30%
Drug Intolerance (drug sensitivity): 19 people, 28.79%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 20 people, 30.30%
Metastases To Bone (cancer spreads to bone): 9 people, 13.64%
Neoplasm Malignant (cancer tumour): 8 people, 12.12%
Metastatic Neoplasm (spreadable cancer tumour): 8 people, 12.12%
Metastases To Prostate (cancer spreads to prostate): 7 people, 10.61%
Mouth Ulcers: 7 people, 10.61%
Type 2 Diabetes: 4 people, 6.06%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 3 people, 4.55%
Depression: 3 people, 4.55%
Osteoporosis (bones weak and more likely to break): 2 people, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Indocin and have Swelling?

- Check whether Swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indocin:

Indocin (4,559 reports)

Swelling treatments and more:

Swelling (115,742 reports)

Browse all side effects of Indocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling:

Swelling (2,298 drugs)

Browse all the conditions that are associated with Swelling:

Swelling (2,891 conditions)

Related publications that referenced our studies

Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C, "Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient", BMC geriatrics, 2012 Nov .
Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C, "Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient", BMC geriatrics, 2012 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on indomethacin (the active ingredients of Indocin) and Indocin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.